Compare · VJET vs WST
VJET vs WST
Side-by-side comparison of Flyte Aviation Inc. (VJET) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both VJET and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- WST is the larger of the two at $28.14B, about 19767.2x VJET ($1.4M).
- VJET has been more active in the news (7 items in the past 4 weeks vs 6 for WST).
- WST has more recent analyst coverage (20 ratings vs 0 for VJET).
- Company
- Flyte Aviation Inc.
- West Pharmaceutical Services Inc.
- Price
- -
- -
- Market cap
- $1.4M
- $28.14B
- 1M return
- -46.97%
- -
- 1Y return
- -97.56%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- AMEX
- NYSE
- IPO
- News (4w)
- 7
- 6
- Recent ratings
- 0
- 20
Flyte Aviation Inc.
Flyte Aviation, Inc. (NYSE American: VJET) is a technology-enabled private aviation company focused on modernizing how consumers access private air travel. Through its Flyte brand, the Company operates a growing fleet of Cirrus Vision Jets and is building a scalable aviation platform designed to connect customers, aircraft, operators, and aviation services. Flyte's simple value proposition: privacy, comfort, reliability, and convenience - at a highly competitive price. Through its direct-to-consumer booking platform, standardized pricing on select routes, strategic partnerships, and FAA-certified Part 135 operating subsidiary, Ponderosa Air, LLC, Flyte is focused on delivering what it believes is a faster, safer and more convenient private aviation experience while expanding its technology, customer network, and geographic footprint.
West Pharmaceutical Services Inc.
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Latest VJET
- Flyte Aviation Reports Record Third Quarter 2026 Aviation Revenue Increasing 145% Sequentially
- Catheter Precision Partners With Two New German Heart Centers
- Flyte Aviation Launches Flyte Club to Disrupt Jet Cards and Fractional Ownership Programs with Transparent Per-Trip Pricing and Savings Up to 30%
- Flyte Aviation Executes Letter of Intent to Sell Cardiology Assets
- Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population
- Flyte Aviation Expands International Operations to Canada
- Flyte Aviation, One of the Nation’s Largest Vision Jet Operators, Congratulates Cirrus Aircraft on Ten Years of Innovation
- Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure Device
- Flyte Aviation Establishes New B2B Distribution Channel, Launches Partner Portal
- Flyte Aviation Partners with The Philadelphia 76ers
Latest WST
- Amendment: SEC Form SCHEDULE 13G/A filed by West Pharmaceutical Services Inc.
- West to Participate in Upcoming Investor Conference
- SEC Form 10-Q filed by West Pharmaceutical Services Inc.
- SEC Form 8-K filed by West Pharmaceutical Services Inc.
- West Reports Third-Quarter 2026 Results
- SEC Form 8-K filed by West Pharmaceutical Services Inc.
- West Declares Quarterly Dividend
- West to Host Third-Quarter 2026 Conference Call
- West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
- SEC Form 4 filed by Director Haugen Janet Brutschea